Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Brenda N. Baak"'
Autor:
Karin M. A. Swart, Brenda N. Baak, Louise Lemmens, Fernie J. A. Penning-van Beest, Camilla Bengtsson, Muriel Lobier, Fabian Hoti, Dina Vojinovic, Lindy van Burk, Kirsty Rhodes, Edeltraut Garbe, Ron M. C. Herings, Clementine Nordon, Sami O. Simons
Publikováno v:
Respiratory Research, Vol 24, Iss 1, Pp 1-10 (2023)
Abstract Background People living with chronic obstructive pulmonary disease (COPD) have an increased risk of experiencing cardiovascular (CV) events, particularly after an exacerbation. Such CV burden is not yet known for incident COPD patients. We
Externí odkaz:
https://doaj.org/article/b7f1bda75ac343adbd4dcaa1bfb633cd
Autor:
Vijay R Varma, Youjin Wang, Yang An, Sudhir Varma, Murat Bilgel, Jimit Doshi, Cristina Legido-Quigley, João C Delgado, Anup M Oommen, Jackson A Roberts, Dean F Wong, Christos Davatzikos, Susan M Resnick, Juan C Troncoso, Olga Pletnikova, Richard O'Brien, Eelko Hak, Brenda N Baak, Ruth Pfeiffer, Priyanka Baloni, Siamak Mohmoudiandehkordi, Kwangsik Nho, Rima Kaddurah-Daouk, David A Bennett, Shahinaz M Gadalla, Madhav Thambisetty
Publikováno v:
PLoS Medicine, Vol 18, Iss 5, p e1003615 (2021)
BackgroundWhile Alzheimer disease (AD) and vascular dementia (VaD) may be accelerated by hypercholesterolemia, the mechanisms underlying this association are unclear. We tested whether dysregulation of cholesterol catabolism, through its conversion t
Externí odkaz:
https://doaj.org/article/2c8a7f7dbbcf4006bcc57756f0be9c11
Autor:
Brenda N Baak, Susan S Jick
Publikováno v:
European Heart Journal - Cardiovascular Pharmacotherapy. 9:58-75
Aims Studies have found an increased risk of myocardial infarction (MI) in association with some non-steroidal anti-inflammatory drugs (NSAIDs). We evaluated this association in patients without major cardiovascular risk factors and assessed potentia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8c8383e29cc891efc2b5031457f31ad
https://doi.org/10.1093/ehjcvp/pvac041
https://doi.org/10.1093/ehjcvp/pvac041
Autor:
Brenda N. Baak, Christos Davatzikos, Dean F. Wong, Juan C. Troncoso, Rima Kaddurah-Daouk, Shahinaz M. Gadalla, Cristina Legido-Quigley, Madhav Thambisetty, Jackson A. Roberts, Anup M. Oommen, Jimit Doshi, Kwangsik Nho, Yang An, Eelko Hak, Priyanka Baloni, Susan M. Resnick, Richard O'Brien, Sudhir Varma, David A. Bennett, Ruth M. Pfeiffer, Vijay R. Varma, Murat Bilgel, Olga Pletnikova, Youjin Wang, João Delgado, Siamak Mohmoudiandehkordi
Publikováno v:
PLOS MEDICINE, 18(5):1003615. PUBLIC LIBRARY SCIENCE
PLoS Medicine
PLoS Medicine, Vol 18, Iss 5, p e1003615 (2021)
PLoS Medicine
PLoS Medicine, Vol 18, Iss 5, p e1003615 (2021)
Background While Alzheimer disease (AD) and vascular dementia (VaD) may be accelerated by hypercholesterolemia, the mechanisms underlying this association are unclear. We tested whether dysregulation of cholesterol catabolism, through its conversion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fa8dab1631b5a6c5d360b0b330945d1
https://research.rug.nl/en/publications/6e5dca98-8679-4476-8c1b-981978449280
https://research.rug.nl/en/publications/6e5dca98-8679-4476-8c1b-981978449280
